Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

22nd Apr 2021 11:53

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing21 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,705,364

1.32%

165,818

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

7,134

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,783,823

1.38%

179,052

0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

238.3900 USD

Purchase

5

235.5400 USD

Purchase

5

235.9500 USD

Purchase

10

235.6600 USD

Purchase

10

235.6800 USD

Purchase

10

236.0050 USD

Purchase

15

235.7133 USD

Purchase

20

235.6937 USD

Purchase

25

235.7440 USD

Purchase

41

236.0713 USD

Purchase

50

236.2726 USD

Purchase

100

236.2400 USD

Purchase

100

236.4600 USD

Purchase

200

236.0800 USD

Purchase

300

236.3650 USD

Purchase

300

236.0300 USD

Purchase

378

236.5308 USD

Purchase

400

236.4262 USD

Purchase

433

235.7446 USD

Purchase

600

236.2625 USD

Purchase

603

236.0504 USD

Purchase

677

235.9449 USD

Purchase

700

236.1900 USD

Purchase

700

236.3092 USD

Purchase

999

236.3390 USD

Purchase

1,499

236.0122 USD

Purchase

1,680

236.1584 USD

Purchase

1,791

236.3913 USD

Purchase

2,002

236.0953 USD

Purchase

2,019

236.0866 USD

Purchase

2,170

235.7369 USD

Purchase

2,314

236.3744 USD

Purchase

2,467

236.2885 USD

Purchase

2,654

236.4454 USD

Purchase

2,997

235.7400 USD

Purchase

3,404

236.2683 USD

Purchase

4,088

235.8832 USD

Purchase

10,358

235.7635 USD

Purchase

16,378

236.2454 USD

Purchase

19,527

235.9352 USD

Sale

3

235.1850 USD

Sale

7

236.4400 USD

Sale

12

235.3025 USD

Sale

27

236.1388 USD

Sale

48

235.8940 USD

Sale

50

236.2726 USD

Sale

63

236.1976 USD

Sale

63

236.2028 USD

Sale

68

236.0730 USD

Sale

75

236.2116 USD

Sale

79

236.1707 USD

Sale

81

236.2551 USD

Sale

82

236.1385 USD

Sale

84

236.3085 USD

Sale

97

236.2544 USD

Sale

100

236.0100 USD

Sale

131

236.7632 USD

Sale

133

236.0851 USD

Sale

184

235.8445 USD

Sale

186

236.1758 USD

Sale

362

235.7646 USD

Sale

426

235.8972 USD

Sale

433

235.7446 USD

Sale

840

236.1584 USD

Sale

1,440

236.0836 USD

Sale

1,654

236.1596 USD

Sale

1,897

236.1010 USD

Sale

2,171

235.7382 USD

Sale

2,358

236.3239 USD

Sale

3,092

236.2519 USD

Sale

4,137

235.7400 USD

Sale

4,688

235.9086 USD

Sale

10,251

235.7601 USD

Sale

22,848

235.9774 USD

Sale

25,000

236.2910 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

22 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

 

date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210422005571/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87